Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 3/20 | 0.32 |
| ▸ | ADH1C | P00326 | 2/20 | 0.32 |
| ▸ | ADH1B | P00325 | 1/20 | 0.32 |
| ▸ | ADH4 | P08319 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9158295 | 1.00 | ADH1A (0.32) | ADH1AADH1CADH1BADH4LMNA | |
| SCHEMBL21457789 | 1.00 | ADH1A (0.32) | ADH1AADH1CADH1BADH4LMNA | |
| SCHEMBL31476927 | 1.00 | ADH1A (0.32) | ADH1AADH1CADH1BADH4LMNA | |
| SCHEMBL31476907 | 1.00 | ADH1A (0.32) | ADH1AADH1CADH1BADH4LMNA | |
| SCHEMBL11827376 | 0.98 | ADH1A (0.31) | ADH1AADH1CADH1BADH4LMNA | |
| SCHEMBL31008449 | 0.97 | LMNA (0.32) | LMNATSHR | |
| SCHEMBL3465699 | 0.95 | ADH1A (0.32) | ADH1AADH1CADH1BADH4 | |
| SCHEMBL3180740 | 0.92 | ADH1A (0.33) | ADH1AADH1CADH1BADH4 | |
| SCHEMBL6588160 | 0.90 | — | — | |
| SCHEMBL19736192 | 0.84 | EPHX1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114380815-A | Phytoalexin derivative and preparation method and application thereof | 河北工业大学 | 2022-04-22 | — | — | CN | claimed |
| CN-114380815-B | Plant protection camalexin derivative and preparation method and application thereof | 河北工业大学 | 2024-05-31 | — | — | CN | disclosed |
| CN-117241803-A | Purine nucleosides, intermediates and methods of making the same | 阿斯特罗赛特制药公司 | 2023-12-15 | — | — | CN | disclosed |
| CN-114380815-A | Phytoalexin derivative and preparation method and application thereof | 河北工业大学 | 2022-04-22 | — | — | CN | disclosed |
| CN-109790284-B | Polyphenol compound and process for producing the same | 三菱化学株式会社 | 2021-09-21 | — | — | CN | disclosed |
| US-10851039-B2 | Polyhydric phenol compound and method of producing same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-12-01 | — | — | US | disclosed |
| US-10793499-B2 | — | — | 2020-10-06 | — | — | US | disclosed |
| EP-3514193-A1 | POLYVALENT PHENOL COMPOUND AND METHOD OF PRODUCING SAME | Mitsubishi Chemical Corporation (JP) | 2019-07-24 | — | — | EP | disclosed |
| US-20190210947-A1 | POLYHYDRIC PHENOL COMPOUND AND METHOD OF PRODUCING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-07-11 | — | — | US | disclosed |
| US-20090143592-A1 | Glucagon Antagonists/Inverse Agonists | NOVO NORDISK A/S (DK) | 2009-06-04 | — | — | US | disclosed |
| US-20030220350-A1 | Glucagon antagonists/inverse agonists | PFIZER INC | 2003-11-27 | — | — | US | disclosed |
| US-6503949-B1 | Treating Type 2 diabetes, hyperglycemia, impaired glucose tolerance or obesity | NORO NORDISK A/S (DK) | 2003-01-07 | — | — | US | disclosed |
| EP-1183229-A1 | GLUCAGON ANTAGONISTS/INVERSE AGONISTS | NOVO NORDISK A/S (DK) | 2002-03-06 | — | — | EP | disclosed |
| EP-0637623-B1 | Cyclic hydrocarbon derivative and liquid crystal composition containing the same | DAINIPPON INK & CHEMICALS (JP) | 2001-10-04 | — | — | EP | disclosed |
| WO-2000069810-A1 | GLUCAGON ANTAGONISTS/INVERSE AGONISTS | NOVO NORDISK A/S (DK) | 2000-11-23 | — | — | WO | disclosed |
| US-5536443-A | DUTERIUM CONTAINING COMPOUNDS FOOR ELECTROOPTICAL APPARATUS | DAINIPPON INK & CHEMICALS, INC. (JP) | 1996-07-16 | — | — | US | disclosed |
| US-5474707-A | Electrooptic display | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1995-12-12 | — | — | US | disclosed |
| EP-0637623-A1 | Cyclic hydrocarbon derivative and liquid crystal composition containing the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1995-02-08 | — | — | EP | disclosed |
| US-4519925-A | Sulfur-containing compounds and lubricants containing them | THE LUBRIZOL CORPORATION (US) | 1985-05-28 | — | — | US | disclosed |
| US-4129510-A | Sulfur-containing compounds and lubricants and fuels containing them | THE LUBRIZOL CORPORATION (US) | 1978-12-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190210947-A1 | POLYHYDRIC PHENOL COMPOUND AND METHOD OF PRODUCING SAME | RB1, FHIT, H1-4 | ADH1A 646/4885ADH1C 467/4885ADH1B 123/4885 |
| US-10851039-B2 | Polyhydric phenol compound and method of producing same | RB1, FHIT, H1-4 | ADH1A 646/4885ADH1C 467/4885ADH1B 123/4885 |
| US-20090143592-A1 | Glucagon Antagonists/Inverse Agonists | GLP1R, GPR119, GCGR | ADH1A 1628/4885ADH1C 1146/4885ADH1B 3930/4885 |
| US-20030220350-A1 | Glucagon antagonists/inverse agonists | GLP1R, GPR119, GCGR | ADH1A 1628/4885ADH1C 1146/4885ADH1B 3930/4885 |
| US-10793499-B2 | — | RB1, H1-4, TPD52L2 | ADH1A 817/4885ADH1C 772/4885ADH1B 138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.